Physiological and metabolic effects of short-term dopamine reduction in healthy horses using a tyrosine hydroxylase inhibitor (alpha-methyl-para-tyrosine).

This study investigates the effects of Alpha-methyl-para-tyrosine (AMPT), a compound that inhibits a key enzyme involved in producing chemicals responsible for transmitting signals in the brain, on dopamine concentrations in horses. The experimental results confirm that a single oral dose of AMPT effectively reduced both central and circulating dopamine levels in healthy horses, with implications for future studies aiming to regulate dopamine in this species.

Research Methodology

• Six healthy adult Standardbred geldings (male horses) were randomly selected to receive AMPT (40 mg/kg body weight) or a placebo in a randomized crossover design where subjects receive a sequence of different treatments.
• Clinical examination findings were recorded.
• Blood samples were collected for up to 6 hours following the administration of AMPT or placebo.
• These samples were analyzed for blood glucose, plasma Adrenocorticotropic hormone (ACTH) and cortisol concentrations, and for a metabolomic analysis.
• AMPT’s effect on dopamine was determined using plasma prolactin concentration as a surrogate index of central dopamine reduction.

Findings

• No adverse clinical effects were detected after the oral administration of AMPT. This was determined through vital signs such as heart rate, mean arterial pressure, and blood glucose concentration, which did not differ significantly between AMPT and placebo treatments.
• The concentration of plasma prolactin peaked 1 hour after AMPT administration, indicating a drop in dopamine levels, then returned to baseline afterwards for all but one horse.
• There was a significant reduction in plasma dopamine (0.72-fold change; P=0.016) 1 hour after treatment with AMPT.
• No significant difference was observed in ACTH and cortisol concentrations between the two treatments.
• Metabolomic analysis revealed slight changes in certain metabolites associated with ketogenesis and amino acid levels.

Implications and Future Research

• The results show that AMPT is effective in reducing dopamine concentration in horses and could be further utilized in pharmacokinetic and pharmacodynamic studies to identify the optimal dose and duration for achieving longer-term dopamine regulation.
• The metabolomic findings suggest that there might be an interruption in energy flux at the time of sample collection, prompting further research into nutritional studies in horses.